Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead. The post Navigating 2025: Three Key Trends Shaping the Future of Pharma appeared first on MedCity News.
Worried that President-elect Donald Trump will curtail federal efforts to take on the nation’s medical debt problem, patient and consumer advocates are looking to states to help people who can’t afford their medical bills or pay down their debts. “The election simply shifts our focus,” said Eva Stahl, who oversees public policy at Undue Medical…
Yuanyin “Sue” Shu is the fastest and most efficient housekeeper working at Children’s Hospital of Colorado in Colorado Springs. In an eight-hour shift, she cleans 26 occupied patient rooms, two rooms where patients have been discharged, as well as sleep rooms and other areas. But her most valued trait is her passion for children. When…
This post looks at federal government databases with key health data that went offline on Jan. 31, 2025, including several related to HIV, some of which had returned by Feb. 2, 2025. It briefly describing the affected databases, which include widely used, large-scale national health surveys, indices, and data dashboards, that inform research, policy making,…
Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and…
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
In the 2024 election, seven out of 10 states passed ballot measures protecting abortion rights. But the effects won’t be seen immediately, experts say. The post 7 States Passed Abortion Rights Ballot Measures. But Changes Won’t be Like a “Light Switch,” Experts Say appeared first on MedCity News.
As we confront the sobering statistics and growing impact of colorectal cancer, it’s clear that more education about the various options for testing is needed to increase screening rates across the U.S. The post A Closer Look at FIT Tests – A Primer on the Various Options for Colorectal Cancer Screening appeared first on MedCity News.
This KFF brief provides key facts about U.S. funding for global health, including the range of efforts the U.S. supports, U.S. agencies/departments involved in global health activities, funding trends, and more.
Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9 billion. Novo Nordisk, a finalist in that pursuit, is positioning itself as a deal spoiler with a new unsolicited offer that shells out much more upfront cash. The post Novo…